PROSIEBENSAT1 MED. NPV (PBSFF) Given Neutral Rating at JPMorgan Chase & Co.
PROSIEBENSAT1 MED. NPV (OTCMKTS:PBSFF)‘s stock had its “neutral” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a research note issued on Friday.
Separately, DZ Bank AG reissued a “sell” rating on shares of PROSIEBENSAT1 MED. NPV in a report on Friday, August 5th.
PROSIEBENSAT1 MED. NPV (OTCMKTS:PBSFF) traded up 3.77% during mid-day trading on Friday, hitting $42.16. 158 shares of the company’s stock were exchanged. The stock has a market capitalization of $9.05 billion and a P/E ratio of 22.17. PROSIEBENSAT1 MED. NPV has a 52 week low of $39.66 and a 52 week high of $53.96. The firm has a 50 day moving average of $44.35 and a 200 day moving average of $46.92.
Receive News & Stock Ratings for PROSIEBENSAT1 MED. NPV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PROSIEBENSAT1 MED. NPV and related stocks with our FREE daily email newsletter.